Shanghai Pharmaceutical Co Ltd (601607) - Financial and Strategic SWOT Analysis Review

Shanghai Pharmaceutical Co Ltd (601607) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler, and distributor of healthcare products. The company carries out the researches, develops, produces, and sells pharmaceutical products for the treatment of HER2 positive advanced breast cancer, systemic anti-infection, and antineoplastic drug and immunomodulator. It also offers medicines for diseases and disorders of cardiovascular system, digestive and metabolism, neurological system, musculoskeletal system, and respiratory system. Shanghai Pharma also provides traditional Chinese medicines. It provides distribution and supply chain solutions to pharmaceutical manufacturers and dispensers; operates retail pharmacy stores; and provides consulting services, assets management and other services. The company operates through its subsidiaries in China. Shanghai Pharma is headquartered in Shanghai, China.

Shanghai Pharmaceutical Co Ltd Key Recent Developments

Sep 30,2019: Shanghai Pharma Global Standard Stock Incentive Scheme to push innovation refiled for approval

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
Shanghai Pharmaceutical Co Ltd - Key Facts
Shanghai Pharmaceutical Co Ltd - Key Employees
Shanghai Pharmaceutical Co Ltd - Key Employee Biographies
Shanghai Pharmaceutical Co Ltd - Major Products and Services
Shanghai Pharmaceutical Co Ltd - History
Shanghai Pharmaceutical Co Ltd - Company Statement
Shanghai Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Shanghai Pharmaceutical Co Ltd - Business Description
Business Segment: Distribution and Supply Chain Solutions
Overview
Performance
Business Segment: Other Business Operations
Overview
Performance
Business Segment: Pharmaceutical Business
Overview
Performance
Business Segment: Pharmaceutical Retail
Overview
Performance
Shanghai Pharmaceutical Co Ltd - Corporate Strategy
Shanghai Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Shanghai Pharmaceutical Co Ltd - Strengths
Shanghai Pharmaceutical Co Ltd - Weaknesses
Shanghai Pharmaceutical Co Ltd - Opportunities
Shanghai Pharmaceutical Co Ltd - Threats
Shanghai Pharmaceutical Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 30, 2019: Shanghai Pharma Global Standard Stock Incentive Scheme to push innovation refiled for approval
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables

 
Shanghai Pharmaceutical Co Ltd, Key Facts
Shanghai Pharmaceutical Co Ltd, Key Employees
Shanghai Pharmaceutical Co Ltd, Key Employee Biographies
Shanghai Pharmaceutical Co Ltd, Major Products and Services
Shanghai Pharmaceutical Co Ltd, History
Shanghai Pharmaceutical Co Ltd, Other Locations
Shanghai Pharmaceutical Co Ltd, Subsidiaries
Shanghai Pharmaceutical Co Ltd, Affiliate
Shanghai Pharmaceutical Co Ltd, Key Competitors
Shanghai Pharmaceutical Co Ltd, Ratios based on current share price
Shanghai Pharmaceutical Co Ltd, Annual Ratios
Shanghai Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Shanghai Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Shanghai Pharmaceutical Co Ltd, Interim Ratios
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


Shanghai Pharmaceutical Co Ltd, Performance Chart (2015 - 2019)
Shanghai Pharmaceutical Co Ltd, Ratio Charts
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Shanghai Commercial Bank Ltd - Strategic SWOT Analysis Review

Shanghai Commercial Bank Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Sinopec Shanghai Petrochemical Co Ltd (600688) - Financial and Strategic SWOT Analysis Review

Sinopec Shanghai Petrochemical Co Ltd (600688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

Leading Pharmaceutical Contract Development Manufacturing Organizations

- Will the industry consolidate, decentralize, or undergo a bimodal transformation - How will the current trends affect the major market segments- Which companies will enter the market and which

USD 3500 View Report

Global Pharmaceutical Continuous Manufacturing Market 2023-2029

For decades, pharmaceutical firms have manufactured their products in batches. To streamline production, manufacturers have begun to apply continuous manufacturing technologies to the pharmaceutical production process. Continuous manufacturing is a

USD 2950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available